Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Tulay, Eren"'
Publikováno v:
Infectious Diseases and Clinical Microbiology. 4:274-279
Objective: Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies, and its most common complication is infection. We aimed to evaluate the patients who
Autor:
Nuriye Ozdemir, Irem Bilgetekin, Esra Zeynelgil, Mustafa Altinbaş, Ismail Erturk, Selin Akturk Esen, Dogan Uncu, Musa Baris Aykan, Goksen Inanc Imamoglu, Yeşim Yıldız, Cengiz Karacin, Ahmet Ozet, Burak Civelek, Ismail Celik, Gokhan Ucar, Fatma Buğdaycı Başal, Nuri Karadurmus, Ozan Yazıcı, Bedia Dinc, Ibrahim Karadag, Omur Berna Oksuzoglu, Osman Sütcüoğlu, Yakup Ergun, Mutlu Dogan, Tulay Eren
Publikováno v:
Future Oncology
Aim: To evaluate the immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Methods: This multicenter, prospective, observational study was conducted with 47 patients receiving active systemic th
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 21, Iss 5, Pp 320-324 (2015)
Background/Aims: The association between platelet–lymphocyte ratio (PLR), neutrophil–lymphocyte ratio (NLR), and survival with response rates were evaluated in metastatic gastric cancer (MGC). Patients and Methods: MGC patients on firstline modif
Externí odkaz:
https://doaj.org/article/e62c7b9d84874cfd9dd2450d7a94ce68
Autor:
Yakup Ergun, Selin Akturk Esen, Murat Bardakci, Gokhan Ucar, Ziya Kalkan, Zuhat Urakci, Erdogan Seyran, Mutlu Dogan, Tulay Eren, Volkan Aslan, Seda Kahraman, Emine Eylem Genc, Yusuf Acikgoz, Merve Dirikoc, Irfan Esen, Dogan Uncu
Publikováno v:
Cancer biomarkers : section A of Disease markers. 34(2)
BACKGROUND: The relationship of the ABO blood group system with the immune response is known, but its relationship with immune checkpoint inhibitors (ICIs) has not been clearly investigated until now. OBJECTIVE: In this study, the relationship betwee
Autor:
Sertaç Çimen, Cengiz Karacin, Nuriye Ozdemir, Gökşen İnanç Imamoğlu, Ebru Cilbir, Dogan Yazilitas, Tulay Eren
Publikováno v:
International Journal of Hematology and Oncology. 29:139-146
Autor:
Özlem Aydın İsak, Ebru Cilbir, Sema Türker, Cengiz Karacin, Tulay Eren, Mustafa Altinbaş, Hayriye Şahinli, Esra Zeynelgil, Dogan Yazilitas, Perihan Perkin, Fevzi Coskun Sokmen, Goksen Inanc Imamoglu
Publikováno v:
Acta Oncologica Turcica. 52:455-462
Autor:
hasan Karadağ, Ramazan Esen, Mustafa Altinbaş, Goksen Inanc Imamoglu, Tulay Eren, Sema Türker, Dogan Yazilitas, Ebru Cilbir, Cengiz Karacin, Hayriye Şahinli
Publikováno v:
Eastern Journal Of Medicine. 24:451-456
Publikováno v:
Volume: 12, Issue: 3 349-356
Turkish Journal of Clinics and Laboratory
Turkish Journal of Clinics and Laboratory
Aim: It is known that approximately 10% of breast cancers are hereditary, and BRCA1/2 genes are responsible forapproximately 20% of these. Studies have shown that mutations of many genes other than BRCA1/2 in breast cancer alsocause this predispositi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32de9fdea1067f73ba16f3e2ce97e150
https://dergipark.org.tr/tr/pub/tjcl/issue/65169/948240
https://dergipark.org.tr/tr/pub/tjcl/issue/65169/948240
Autor:
Neslihan Duzkale, Tugba Taskin Turkmenoglu, Tulay Eren, Suayip Yalcin, Ozlem Oz, Kadir Cetinkaya
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 30(7)
Objective To investigate the genetic causes of colorectal cancers (CRCs); and to determine the genotype-phenotype correlation. Study design Descriptive study. Place and duration of study Department of Medical Genetics, Diskapi Yildirim Beyazit Traini
Autor:
Yusuf Acikgoz, Oznur Bal, Mutlu Dogan, Mehmet Ali Nahit Sendur, Nuri Karadurmus, Cengiz Karacin, Omur Berna Oksuzoglu, Tulay Eren, Goksen Inanc Imamoglu, Ramazan Acar
Publikováno v:
Supportive Care in Cancer
Purpose COVID-19 will continue to disrupt the diagnosis-treatment process of cancer patients. Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital has been considered as a ‘non-pandemic’ center (‘clean’) in Ankara, the capital city of Turkey. T